NCT04139889

Brief Summary

To evaluate the diagnosis of laryngeal lesions using the Probe-based Confocal Laser Endomicroscopy in vivo.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

October 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 25, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2020

Completed
Last Updated

January 7, 2020

Status Verified

January 1, 2020

Enrollment Period

2.5 years

First QC Date

October 22, 2019

Last Update Submit

January 4, 2020

Conditions

Keywords

Probe-based confocal laser endomicroscopyOptical biopsy

Outcome Measures

Primary Outcomes (1)

  • pCLE diagnostic classification

    Evaluation of pCLE diagnostic performance for the diagnosis of Laryngeal Lesions when associated with other diagnostic information.

    6 months

Secondary Outcomes (1)

  • the image analysis by machine learning

    6 months

Study Arms (3)

normal mucosa

Flat and relatively uniform polygonal epithelial cells with alternating dark and light bands were noted in pCLE images of normal mucosa after intravenous injecting 10% fluorescein.

Diagnostic Test: Confocal Laser Endomicroscopy

non-malignant lesions

An unorganized tissue architecture, irregular cells (difference of cell shape, color and size), slightly intensified fluorescein leakage, and vessels not assessable were found in the lymphoid hyperplasia of non-malignant lesions after intravenous injecting 10% fluorescein.

Diagnostic Test: Confocal Laser Endomicroscopy

malignant lesions

pCLE images of malignant lesions were associated with crowded unorganized tissue architecture (a dark-gray background without identification of mucosal structures), irregular cells like cell clusters, amplified fluorescein leakage, and irregular vessels changes after intravenous injecting 10% fluorescein.

Diagnostic Test: Confocal Laser Endomicroscopy

Interventions

Confocal laser microendoscopy (CLE) as a new non-invasive imaging technique can be used for "optical biopsy", which can perform real-time microscopic information of tissue in vivo at cellular level with resolutions up to 1μm and magnifications up to 1000 times. CLE is now being increasingly used with very promising results in gastroenterology, especially in the diagnostic investigation of Barret's esophagus, stomach cancer, colorectal cancer and various lesions of the biliary tract. With an intravenous injection of fluorescein, probe-based CLE (pCLE: GastroFlex probe with the Cellvizio laser system, Mauna Technologies, Paris, France) allows us to view the interstitial spaces, cells, and small capillaries in a window of 240 μm and to a depth of 60 μm.

malignant lesionsnon-malignant lesionsnormal mucosa

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with suspicious unidentified lesions were collected in this study in Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, who need to be underwent microscopic laryngoscopy.

You may qualify if:

  • ≤Male or female age ≤85 years old;
  • patients with vocal cord lesions founded by white light laryngoscope and needed to perform laryngeal microsurgery;
  • Willing and able to comply with study procedures and provide written informed consent to participate in the study.

You may not qualify if:

  • Male or female \<18 years old, or Male or female \>85 years;
  • The patient has abnormal blood or coagulation function, and there is a risk of bleeding during the examination;
  • The patient has severe cardiopulmonary function or liver and kidney dysfunction and cannot tolerate surgery.
  • The patient has a history of allergies to drugs or food.
  • The patient has a positive serotonin sodium allergy test and is allergic to sodium fluorescein;
  • Lactation or pregnant women.
  • Refusal to sign the informed consent form.
  • Others who do not take this test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University

Shanghai, Shanghai Municipality, 200031, China

RECRUITING

Study Officials

  • Huawei Li, PhD &MD

    Otorhinolaryngology Department of Eye & ENT Hospital, Fudan University

    STUDY CHAIR

Central Study Contacts

Lingjie Wu, PhD &MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2019

First Posted

October 25, 2019

Study Start

June 1, 2017

Primary Completion

November 30, 2019

Study Completion

December 21, 2020

Last Updated

January 7, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations